Skip to main
KALV
KALV logo

KalVista Pharma (KALV) Earnings Dates & Reports

KalVista Pharma (KALV) Most Recent Earnings

Report DateDec 5, 2024
Period EndingQ2 2025
Est. EPS-$0.91
Actual EPS-$0.91
EarningsMeet

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KalVista Pharma (KALV) Earnings per Share (EPS) History

Signup for full access
Browse free

KalVista Pharma (KALV) Latest Earnings

The value each KALV share was expected to gain vs. the value each share gained.

KalVista Pharma (KALV) reported its most recent earnings on Dec 5, 2024 for Q2 2025, posting earnings per share (EPS) of -$0.91. This exceeded analysts' expectations of -$0.91 by 0.00%, marking a Meet.

For comparison, KalVista Pharma reported EPS of -$0.80 in the same quarter last year.

The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of -$1.02.

KalVista Pharma (KALV) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Mar 12, 2025
-$1.02Next earnings call Nov. 11, 2025
Q2 2025Dec 5, 2024
-$0.91-$0.910.00%
Q1 2025Sep 5, 2024
-$0.86-$0.87+1.16%
Q4 2024Jul 11, 2024
-$0.73-$1.02+39.73%
Q3 2024Mar 11, 2024
-$0.77-$0.84+9.09%
View all

KalVista Pharma (KALV) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the KalVista Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Dec 5, 2024
Sep 5, 2024
Jul 11, 2024
Mar 11, 2024

KalVista Pharma (KALV) Earnings FAQs

KalVista Pharma (KALV) last reported earnings on Dec 5, 2024 for Q2 2025, posting an EPS of -$0.91, which Meet the estimate of -$0.91 by 0.00%.

For Q2 2025, KalVista Pharma (KALV) reported an EPS of -$0.91, missing analysts' estimate of -$0.91 by 0.00%.

For Q2 2025, KalVista Pharma (KALV) Meet expectations with an actual EPS of -$0.91 vs. an estimated EPS of -$0.91.

Following the last earnings report on Dec 5, 2024, KalVista Pharma (KALV)'s stock price moved — from — to —.

The next KalVista Pharma (KALV) earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.

KalVista Pharma (KALV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.